This is a community-generated profile. If you would like to claim it, please .
Ipsen
Develops/markets innovative medicines for oncology, neuroscience, and rare diseases5000+ EmployeesActively Hiring
Ipsen Funding
$541.1M
11 round
Ipsen is active in the following markets / industries: professional services. The company has secured funding across 1 rounds, totaling in an amount of $541.1M. Their most recent funding was raised on March 19, 2025.
Funding Rounds
S
$541125541